Market Currents
Mela Sciences (MELA) +83% premarket after the FDA issues an "approvable letter" for its medical...
-
Monday, September 26, 2011, 9:05 AM ETMela Sciences (MELA) +83% premarket after the FDA issues an "approvable letter" for its medical device that aims to help doctors more accurately diagnose melanoma. Previously the agency had called on the company to conduct a large new study of the MelaFind device, which already is approved for use in 27 European countries.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
